Timing of bifidobacterium administration influences the development of allergy to ovalbumin in mice.
Kim, H; Lee, SY; Ji, GE
Biotechnology letters, 27(18):1361-1367, 2005
C3H/HeJ mice were sensitized with ovalbumin (OVA) and choleratoxin (CT) for 5 weeks, and then Bifidobacterium bifidum BGN4 was administered continuously for 7 weeks, starting 2 weeks before (pre-treatment group) and 2 weeks after (post-treatment group) the initial sensitization. After sensitization, the OVA-induced (sham group) mice showed growth inhibition and had scab-covered tails which was associated with serum levels of 9887+/-175 ng OVA-specific IgE/ml and 758+/-525 ng IgG1/ml. The sera of the pre-treatment group had 4805+/-245 ng OVA-specific IgE/ml and 193+/-87 ng IgG1/ml, as well as less severe tail symptoms. The sera of the post-treatment group had 5723+/-207 ng OVA-specific IgE/ml but the IgG1 and IgG2a levels were the same as those of the sham group. In spleen cultures, both pre-treatment and post-treatment increased the levels of IFN-gamma but decreased the levels of IL-6 and IL-18. Taken together, the in vivo and in vitro results show that treatment with Bifidobacterium before OVA sensitization suppresses or modulates the allergic response more effectively than treatment with Bifidobacterium following OVA sensitization.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,699,432
Total Download :1,099,672
Today View :401
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.